Flavonoid binding to a multi-drug-resistance transporter protein: an STD-NMR study

Nissler, Ludwig; Gebhardt, Rolf; Berger, Stefan
August 2004
Analytical & Bioanalytical Chemistry;Aug2004, Vol. 379 Issue 7/8, p1045
Academic Journal
Flavonoids are well known to inhibit the function of the multi-drug-resistance (mdr) transporter by interacting with their ATP binding domains. The precise orientation of these molecules inside the ATP binding pocket is still unclear. We applied the saturation transfer difference (STD) NMR technique to investigate the binding of the flavonoid luteolin and its 7-O-β-D- glycopyranoside to the recombinant nucleotide binding domain (NBD2) of mouse-mdr. First, this NMR technique confirmed binding of both ligands to NBD2, as was determined from tryptophan fluorescence-quenching experiments. Further, the results suggest binding of both luteolin and its 7-O-β-D-glycopyranoside by their polar groups at positions 4, 5, and 3' to the protein.


Related Articles

  • Phytochemical Study of Glycosmis mauritiana.  // American Journal of Plant Sciences;Nov2011, Vol. 2 Issue 5, p657 

    The article discusses a phytochemical research involving Glycosmis mauritania. Traditionally used as medicine, the genus Glycosmis is described to have plant flavonoids that tend to exhibit antibacterial, anti-inflammatory and antioxidant properties. It reports on experimental details which...

  • In vitro Efficacy of Flavonoids from Eugenia jambolana Seeds Against ESβL-Producing Multidrug-Resistant Enteric Bacteria. Jamine, R.; Daisy, P.; Selvakumarb, B. N. // Research Journal of Microbiology;2007, Vol. 2 Issue 4, p369 

    Methanol extracts of Eugenia jambolana seeds (Myrtaceae), used as a traditional folklore medicine, showed inhibitory effects against the growth of a few multidrug-resistant extended spectrum beta lactamase (ESβL) producing gram-negative bacteria. Bioactivity guided fractionation yielded...

  • Status of Flavonols as P-Glycoprotein Inhibitors in Cancer Chemotherapy. Bansal, Tripta; Jaggi, Manu; Khar, Roop K.; Talegaonkar, Sushama // Current Cancer Therapy Reviews;2009, Vol. 5 Issue 2, p89 

    Cancer treatment by drugs is seriously limited by P-glycoprotein (P-gp) associated multi-drug resistance (MDR) in various tumor cells. It is now widely recognized that P-gp influences drug transport across various biological membranes. P-gp transporter is widely present in various body tissues...

  • Amino Acid Prodrugs: An Approach to Improve the Absorption of HIV-1 Protease Inhibitor, Lopinavir. Patel, Mitesh; Mandava, Nanda; Gokulgandhi, Mitan; Pal, Dhananjay; Mitra, Ashim K. // Pharmaceuticals;Jun2014, Vol. 7 Issue 6, p433 

    Poor systemic concentrations of lopinavir (LPV) following oral administration occur due to high cellular efflux by P-glycoprotein (P-gp) and multidrug resistance-associated proteins (MRPs) and extensive metabolism by CYP3A4 enzymes. In this study, amino acid prodrugs of LPV were designed and...

  • Investigating transport proteins by solid state NMR. Basting, Daniel; Lehner, Ines; Lorch, Mark; Glaubitz, Clemens // Naunyn-Schmiedeberg's Archives of Pharmacology;Mar2006, Vol. 372 Issue 6, p451 

    Transporters form an interesting and complex class of membrane proteins. Many of them are potential drug targets due to their role in translocation of ions, small molecules and peptides across the membrane or due to their role in multidrug resistance. Hence elucidating their structure and...

  • Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transfer. Cmejlova, J; Hildinger, M; Cmejla, R; Fuchs, O; Kalabova, D; Baum, C; Jelinek, J // Gene Therapy;Jun2003, Vol. 10 Issue 12, p1061 

    The multidrug resistance 1 (MDR1) gene transfer to hematopoietic cells for protection against cytotoxic drugs has received considerable attention in gene therapy. However, ectopic expression of MDR1 from retroviral vectors has been hampered by its genetic instability resulting from cryptic...

  • Definition of the domain boundaries is critical to the expression of the nucleotide-binding domains of P-glycoprotein. Kerr, Ian D.; Berridge, Georgina; Linton, Kenneth J.; Higgins, Christopher F.; Callaghan, Richard // European Biophysics Journal;2003, Vol. 32 Issue 7, p644 

    Heterologous expression of domains of eukaryotic proteins is frequently associated with formation of inclusion bodies, consisting of aggregated mis-folded protein. This phenomenon has proved a significant barrier to the characterization of domains of eukaryotic ATP binding cassette (ABC)...

  • Circumvention of multidrug resistance with anti-P-glycoprotein antibodies: Clinical potential or... Beck, William T. // JNCI: Journal of the National Cancer Institute;1/18/95, Vol. 87 Issue 2, p73 

    Discusses issues in the circumvention of multidrug resistance with anti-P-glycoprotein (Pgp) antibodies. Therapy resistance as an impediment to neoplastic disease treatment; Multidrug resistance associated with overexpression of Pgp; Efficacy and value of circumvention strategies; Clinical...

  • Subcellular Detection and Localization of the Drug Transporter P-Glycoprotein in Cultured Tumor Cells. A. Molinari; A. Calcabrini; S. Meschini; A. Stringaro; P. Crateri; L. Toccacieli; M. Marra; M. Colone; M. Cianfriglia; G. Arancia // Current Protein & Peptide Science;Dec2002, Vol. 3 Issue 6, p653 

    In vitro studies on the cellular location of P-glycoprotein (Pgp) are reported with the aim to clarify the relationship between its intracellular expression and the multidrug resistance (MDR) level of tumor cells. Pgp was found abnormally expressed on the plasma membrane of tumor cells with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics